Percentage | Number of cases | |
---|---|---|
Clinical features | ||
Chronic urticaria | 100% | 281 |
Pruritus | 21% | 58 |
Intermittent fever | 72% | 203 |
Arthralgia, rarely overt arthritis | 68% | 192 |
Bone pain | 55% | 155 |
Weight loss | 16% | 45 |
Angioedema | 8% | 22 |
Lymphadenopathy | 26% | 72 |
Hepatomegaly | 9% | 24 |
Splenomegaly | 6% | 17 |
Neuropathy | 7% | 20 |
Laboratory investigations | ||
Elevated ESR/CRP | 97% | 174/179 |
Leukocytosis | 75% | 115/153 |
Anemia | 63% | 62/98 |
paraprotein | 100% | 281 |
IgMκ total | 85% | 232 |
IgMκ monoclonal | 79% | 222 |
IgMλ monoclonal | 8% | 22 |
IgGκ monoclonal | 5% | 13 |
IgGλ monoclonal | 1% | 4 |
IgM, type not specified | 2% | 7 |
Ig, type not specified | 1% | 3 |
IgMκ & IgMλ | 1% | 3 |
IgMκ & IgMκ & IgMλ | 0,4% | 1 |
IgMκ & IgGκ | 0,4% | 1 |
IgMλ & IgGκ | 0,4% | 1 |
IgMκ & IgAκ | 0,4% | 1 |
IgMκ & IgAλ | 0,4% | 1 |
IgMκ > IgGκ > undetectable | 0,4% | 1 |
IgMκ > polyclonal | 0,4% | 1 |
κ light chain subtype | 89% | 249/281 |
Bence Jones proteins | 23% | 14/62 |
Skin biopsies | ||
dominant histological features | 100% | 207 |
Neutrophils | 50% | 104 |
Lymphocytes +/− macrophages | 5% | 11 |
Macrophages | 5% | 11 |
Vasculitis | 20% | 41 |
Otherwise (mostly unspecified, no vasculitis) | 19% | 40 |
immune deposits | 100% | 83 |
None | 70% | 58 |
Present | 30% | 25 |
IgM | 23% | 19 |
IgG | 2% | 2 |
C3 | 14% | 12 |
Skeletal examinations | ||
conventional radiographs | 100% | 146 |
Normal | 57% | 83 |
Hyperostosis | 39% | 57 |
osteolysis | 1% | 2 |
Periostal reaction | 0,7% | 1 |
Arthritis | 0,7% | 1 |
Abnormal, not specified | 1% | 2 |
scintigraphy | 100% | 97 |
Normal | 13% | 13 |
Increased uptake | 85% | 82 |
Infarctions tibiae | 1% | 1 |
Osteomyelitis | 1% | 1 |
bone biopsy | 100% | 14 |
Normal | 43% | 6 |
Sclerosis | 29% | 4 |
Increased osteoblast & -clast activity | 14% | 2 |
Inflammation | 7% | 1 |
Aspecific | 7% | 1 |
Bone marrow aspirates or biopsies | 100% | 164 |
Normal | 63% | 104 |
Malignancy* | 21%** | 34 |
Plasmacytosis | 9% | 15 |
Otherwise (mostly aspecific) | 7% | 11 |